Labquality EQAS by Aurevia
Mycoplasma genitalium, drug resistance, nucleic acid detection
CLINICAL MICROBIOLOGY
Scheme information
Service
Labquality EQAS
Scheme
Mycoplasma genitalium, drug resistance, nucleic acid detection
Service provider
Aurevia
Accreditation
Not accredited
Status
Running
Target
Laboratories
Coverage
Analytical phase
Rounds
4
Distributions
Globally available
Coordinators
Kati Luiro
Experts
Marianne Gunell
Products
5254 /
Mycoplasma genitalium, drug resistance, nucleic acid detection
Samples: 3 simulated swab samples
Type: Physical sample
Examinations: M. genitalium nucleic acid detection, macrolide (azithromycin) susceptibility.
Additional information: The samples are suitable for all M. genitalium NAT methods and primarily intended for methods detecting point mutations causing macrolide resistance. The samples contain hDNA.
Contact us
Kati Luiro
EQA Coordinator
kati.luiro@aurevia.com
+358 9 8566 8200